Reventa™

  • All Products
  • By Generic
  • By Therapeutic Segment

Reventa™

Therapeutic Segment: Anti-Osteoporotic

Generic Name: Alendronate sodium

Indication:

 

  • In postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures).
  • In postmenopausal women who are at risk of developing osteoporosis.
  • For the treatment of osteoporosis in men to prevent
    fractures.
  • For the treatment and prevention of glucocorticoid-induced osteoporosis and for treatment of Paget’s disease in men and women.

Available as:

Tablets
  • 10MG
  • 70MG